Let's Chat

Predict a more accurate subject pool

Discover the exact population of qualified patients across your subject pool and automatically route them into screening.

Let's Chat
Discover patients
Quickly match patient medical histories to study criteria.
Route subjects
Automatically route qualified patient profiles to site CRCs.
Control data
Maintain ownership and control of your data.

Discover the sites with the highest number of eligible patients matching your study criteria

Know exactly which patients to recruit before trial start-up - increasing the probability of meeting and exceeding recruitment goals.

Know how many pre-screened patients are at your sites

Discover the exact population of qualified patients across your subject pool and automatically route them into screening.

> 160,000

Patient medical records (EMRs) phenotyped

Reduce study costs and improve timelines while remaining HIPAA and GDPR compliant

Provide sponsors with automatically pre-screened patient numbers by quickly matching patient medical histories to specific study criteria.

Reduce costs and minimize expenses

Study recruitment and project timeline risk is reduced through precise patient medical history to trial criteria matching.

Each clinical phenotype is devoid of Patient Identifiable Information (PII) thus addressing concerns around HIPAA and GDPR compliance.

Explore relationships between criteria,
sites and patient data

Phenotyping automates subject pool selection by providing accurate insights into qualified patients available at specific clinical sites.

Medical data

Doctor's notes
Lab data
Billing data, etc.

NCBO Bioportal

SNOMED
MedDRA
RxNorm, etc.
NLP

Patient Phenotypes

Unique ontological profiles containing multiple concept IDs are created for each patient.
Concept ID
A "UMLS concept"
representing one or more ontological terms.
E.g. C0042478

"Aloha's AI technology is a game changer! They quickly matched our trial with relevant sites with qualified patients, and connected us with the site management services needed to get our trial up and running in no time"!

Ulrich Thienel
CEO
ReAlta Life Sciences Inc.

"Aloha's AI phenotyping process and site-to-trial matching service has allowed us to find the optimal trials for my site network. In addition, their automated patient pre-screening saves us much time and money and increases our margins."

Brad Hightower
CEO
Hightower Clinical